Brokerages Anticipate Anika Therapeutics Inc. (NASDAQ:ANIK) to Post $0.47 EPS


Anika Therapeutics Inc. has been given a consensus broker rating score of 1.00 from the two brokers that provide coverage for the stock, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy recommendation.



from Biotech News